亚太国家降钙素原(PCT)指导抗生素管理的适应性专家共识
该共识基于专家会议和Delphi流程,评估了PCT指导抗生素管理在亚太地区的适用性。专家认为现有证据(PCT截断值、诊断预后和抗生素管理重点、推翻标准及临床适应性)对亚太地区急性呼吸道感染和脓毒症患者普遍有效。但热带疾病患者数据库不足限制其临床效用,且资源较低可能导致生物标志物测量频率降低,仅在治疗变化极可能时测量。结论是PCT指导抗生素管理结合持续教育和定期反馈有潜力改善亚太地区抗生素利用,但需调整现有算法并进一步研究热带疾病患者的最佳使用。
要点
- 专家共识认为PCT指导抗生素管理对亚太地区急性呼吸道感染和脓毒症患者普遍有效,包括PCT截断值、诊断预后和抗生素管理重点、推翻标准及临床适应性。
- 热带疾病患者数据库不足,目前限制PCT在这些患者中的临床效用。
- 由于资源可用性较低,生物标志物水平可能测量频率降低,仅在治疗变化极可能时测量。
- 使用PCT指导抗生素管理结合持续教育和定期反馈,有高潜力改善亚太地区抗生素治疗利用。
- 需要进一步研究以了解PCT在热带疾病患者中的最佳使用。
适用人群与场景
- 亚太地区急性呼吸道感染和脓毒症患者,包括危重和非危重人群。
- 热带疾病患者因数据库不足,PCT临床效用受限。
处置流程与药物剂量
- 专家共识提出两个PCT算法,分别用于危重患者和非危重患者,基于柏林共识算法调整。
- 由于资源可用性较低,PCT测量频率可能降低,仅在治疗变化极可能时测量。
研究设计与关键结果
- 通过Delphi流程,专家小组就危重和非危重患者群体的两个PCT算法达成共识。
- 专家认为现有PCT指导抗生素管理证据在亚太地区急性呼吸道感染和脓毒症患者中普遍有效,包括PCT截断值、诊断预后和抗生素管理重点、推翻标准及临床适应性。
- 专家指出热带疾病患者数据库不足,限制PCT临床效用。
- 由于资源可用性较低,生物标志物水平可能测量频率降低,仅在治疗变化极可能时测量。
证据类型、等级与局限
- 证据类型:专家共识(基于Delphi流程的专家意见)。
- 局限:热带疾病患者数据库不足;资源可用性较低可能影响PCT测量频率。
对床旁实践的改变
- 作者认为PCT指导抗生素管理结合持续教育和定期反馈,有高潜力改善亚太地区抗生素治疗利用,但需调整现有算法以适应感染类型和常规临床护理差异。
- 作者认为需要进一步研究以了解PCT在热带疾病患者中的最佳使用。
指南或共识出处
- 专家共识会议:Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting.
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Introduction Recently, an expert consensus on optimal use of procalcitonin (PCT)-guided antibiotic stewardship was published focusing mainly on Europe and the United States. However, for Asia-Pacific countries, recommendations may need adaptation due to differences in types of infections, available resources and standard of clinical care. Methods Practical experience with PCT-guided antibiotic stewardship was discussed among experts from different countries, reflecting on the applicability of the proposed Berlin consensus algorithms for Asia-Pacific. Using a Delphi process, the group reached consensus on two PCT algorithms for the critically ill and the non-critically ill patient populations. Results The group agreed that the existing evidence for PCT-guided antibiotic stewardship in patients with acute respiratory infections and sepsis is generally valid also for Asia-Pacific countries, in regard to proposed PCT cut-offs, emphasis on diagnosis, prognosis and antibiotic stewardship, overruling criteria and inevitable adaptations to clinical settings. However, the group noted an insufficient database on patients with tropical diseases currently limiting the clinical utility in these patients. Also, due to lower resource availabilities, biomarker levels may be measured less frequently and only when changes in treatment are highly likely. Conclusions Use of PCT to guide antibiotic stewardship in conjunction with continuous education and regular feedback to all stakeholders has high potential to improve the utilization of antibiotic treatment also in Asia-Pacific countries. However, there is need for adaptations of existing algorithms due to differences in types of infections and routine clinical care. Further research is needed to understand the optimal use of PCT in patients with tropical diseases.
参考来源
- Lee CC, Kwa ALH, Apisarnthanarak A, et al. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting. Clin Chem Lab Med. 2020. PMID: 31926074. doi:10.1515/cclm-2019-1122
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。